apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies
• 2012 PRNewswire via COMTEXapceth GmbH & Co. KG, located in Munich, Germany, and Indivumed GmbH, based in Hamburg, Germany, have entered into a partnership for the development of a predominantly tissue-based biomarker strategy for the treatment of solid cancers with cellular a